Huiqin Wang
Changsha, 410208, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Corrigendum "Novel antidepressant mechanism of hypericin: Role of connexin 43-based gap junctions" [Biomed. Pharmacother. 167 (2023) 115545].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 10, 2026
Dihydromyricetin Ameliorates Myocardial Ischemia-Reperfusion Injury by Modulating CKLF1-Mediated Cardiomyocyte Pyroptosis.
Journal: Phytotherapy research : PTR
Published: October 13, 2025
New perspective on central nervous system disorders: focus on mass spectrometry imaging.
Journal: Analytical methods : advancing methods and applications
Published: November 07, 2024
Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 29, 2024
Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseases.
Journal: Ageing research reviews
Published: July 26, 2024
Correction to: Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes.
Correction to: Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes.
Journal: Cellular and molecular neurobiology
Published: July 11, 2024
Novel antidepressant mechanism of hypericin: Role of connexin 43-based gap junctions.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 18, 2023
Higenamine exerts antidepressant effect by improving the astrocytic gap junctions and inflammatory response.
Journal: Journal of affective disorders
Published: June 24, 2023
Exogenous Adenosine Antagonizes Excitatory Amino Acid Toxicity in Primary Astrocytes.
Journal: Cellular and molecular neurobiology
Published: November 18, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026